| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d02da00d36bd9118a72f7cd42b4d126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb56eebd05e6d12d3bf5b5d0adfbe517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e4a1c88f8cd2ad54842de7c0e949490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd0cfc63a814d6edd9975b86d0efb14a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3882 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
1994-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_560f18e6a3707b90a556e2e743f61212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a78d7625a5194db71fec8f3e631592cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a43b5c70715782992411ceccac21dab9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae2ce84338482d14acb9c224a3b73f61 |
| publicationDate |
1995-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9510286-A1 |
| titleOfInvention |
Inhibitors of phosphoinositide-specific phospholipase c |
| abstract |
The present invention is directed to novel α-hydroxy-phosphonate compounds which inhibit mammalian phosphoinositide-specific phospholipase-C. The compounds are potent inflammatory and analgesic agents and may be useful for the treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1504013-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03094852-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1504013-A2 |
| priorityDate |
1993-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |